These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 18818926)

  • 21. The effect of prior bisphosphonate therapy on the subsequent BMD and bone turnover response to strontium ranelate.
    Middleton ET; Steel SA; Aye M; Doherty SM
    J Bone Miner Res; 2010 Mar; 25(3):455-62. PubMed ID: 20201000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cost-effectiveness of strontium ranelate in the UK for the management of osteoporosis.
    Borgström F; Ström O; Coelho J; Johansson H; Oden A; McCloskey E; Kanis JA
    Osteoporos Int; 2010 Feb; 21(2):339-49. PubMed ID: 19513577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-utility of long-term strontium ranelate treatment for postmenopausal osteoporotic women.
    Hiligsmann M; Bruyère O; Reginster JY
    Osteoporos Int; 2010 Jan; 21(1):157-65. PubMed ID: 19350339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An economic evaluation of strontium ranelate in the treatment of osteoporosis in a Swedish setting: based on the results of the SOTI and TROPOS trials.
    Borgström F; Jönsson B; Ström O; Kanis JA
    Osteoporos Int; 2006 Dec; 17(12):1781-93. PubMed ID: 17009083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vertebral anti-fracture efficacy of strontium ranelate according to pre-treatment bone turnover.
    Collette J; Bruyère O; Kaufman JM; Lorenc R; Felsenberg D; Spector TD; Diaz-Curiel M; Boonen S; Reginster JY
    Osteoporos Int; 2010 Feb; 21(2):233-41. PubMed ID: 19436941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strontium ranelate reduces the risk of vertebral fracture in young postmenopausal women with severe osteoporosis.
    Roux C; Fechtenbaum J; Kolta S; Isaia G; Andia JB; Devogelaer JP
    Ann Rheum Dis; 2008 Dec; 67(12):1736-8. PubMed ID: 18713788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strontium ranelate for osteoporosis?
    Drug Ther Bull; 2006 Apr; 44(4):29-32. PubMed ID: 16617933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study.
    Reginster JY; Seeman E; De Vernejoul MC; Adami S; Compston J; Phenekos C; Devogelaer JP; Curiel MD; Sawicki A; Goemaere S; Sorensen OH; Felsenberg D; Meunier PJ
    J Clin Endocrinol Metab; 2005 May; 90(5):2816-22. PubMed ID: 15728210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of strontium ranelate in Asian women with postmenopausal osteoporosis.
    Hwang JS; Chen JF; Yang TS; Wu DJ; Tsai KS; Ho C; Wu CH; Su SL; Wang CJ; Tu ST
    Calcif Tissue Int; 2008 Nov; 83(5):308-14. PubMed ID: 18843436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strontium ranelate prevents quality of life impairment in post-menopausal women with established vertebral osteoporosis.
    Marquis P; Roux C; de la Loge C; Diaz-Curiel M; Cormier C; Isaia G; Badurski J; Wark J; Meunier PJ
    Osteoporos Int; 2008 Apr; 19(4):503-10. PubMed ID: 17929073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective assessment of thoracic kyphosis in postmenopausal women with osteoporosis.
    Roux C; Fechtenbaum J; Kolta S; Said-Nahal R; Briot K; Benhamou CL
    J Bone Miner Res; 2010 Feb; 25(2):362-8. PubMed ID: 19594302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficacy of strontium ranelate for the mineralization of bone in postmenopausal women].
    Basurto L; Zárate A; Córdova N; Saucedo R; Galván R; Campos S; Hernández M
    Ginecol Obstet Mex; 2009 May; 77(5):227-30. PubMed ID: 19496517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strontium ranelate: a review of its use in the treatment of postmenopausal osteoporosis.
    Deeks ED; Dhillon S
    Drugs; 2010 Apr; 70(6):733-59. PubMed ID: 20394457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strontium ranelate: an increased bone quality leading to vertebral antifracture efficacy at all stages.
    Ortolani S; Vai S
    Bone; 2006 Feb; 38(2 Suppl 1):19-22. PubMed ID: 16455319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strontium is incorporated into mineral crystals only in newly formed bone during strontium ranelate treatment.
    Li C; Paris O; Siegel S; Roschger P; Paschalis EP; Klaushofer K; Fratzl P
    J Bone Miner Res; 2010 May; 25(5):968-75. PubMed ID: 19874195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and methodology of the phase 3 trials for the clinical development of strontium ranelate in the treatment of women with postmenopausal osteoporosis.
    Meunier PJ; Reginster JY
    Osteoporos Int; 2003; 14 Suppl 3():S66-76. PubMed ID: 12730769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strontium ranelate in post-menopausal osteoporosis.
    Przedlacki J
    Endokrynol Pol; 2011; 62(1):65-72. PubMed ID: 21365582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Strontium ranelate in post-menopausal osteoporosis].
    Przedlacki J
    Endokrynol Pol; 2011; 62 Suppl 2():23-31. PubMed ID: 22125019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strontium ranelate: a novel treatment for postmenopausal osteoporosis: a review of safety and efficacy.
    Blake GM; Fogelman I
    Clin Interv Aging; 2006; 1(4):367-75. PubMed ID: 18046914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of prior bisphosphonate therapy on the subsequent therapeutic effects of strontium ranelate over 2 years.
    Middleton ET; Steel SA; Aye M; Doherty SM
    Osteoporos Int; 2012 Jan; 23(1):295-303. PubMed ID: 21274515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.